Detalhe da pesquisa
1.
Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
N Engl J Med
; 389(10): 911-921, 2023 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37672694
2.
Outcomes of non-angiosarcoma radiation-associated soft tissue sarcomas of the chest.
J Surg Oncol
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38864186
3.
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology.
J Surg Oncol
; 127(5): 871-881, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779385
4.
Patient Understanding of Chemotherapy and Goals of Care as Provided by Different Care Team Members.
J Cancer Educ
; 38(4): 1215-1223, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36595214
5.
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Lancet Oncol
; 21(8): 1110-1122, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702309
6.
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
Oncologist
; 25(11): e1655-e1662, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32701199
7.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787526
8.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Lancet Oncol
; 18(11): 1493-1501, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28988646
9.
A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome.
Support Care Cancer
; 25(3): 833-838, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27838777
10.
S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.
Oncologist
; 20(12): 1353-4, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26576593
11.
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 14(4): 371-82, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23477833
12.
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Cancer Med
; 12(2): 1532-1539, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950293
13.
Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast.
Clin Cancer Res
; 29(15): 2885-2893, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37223927
14.
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology.
J Clin Oncol
; 41(31): 4842-4848, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523624
15.
Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors.
J Surg Res
; 177(2): 248-54, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22831567
16.
New School Technology Meets Old School Technique: Intensity Modulated Proton Therapy and Laparoscopic Pelvic Sling Facilitate Safe and Efficacious Treatment of Pelvic Sarcoma.
Adv Radiat Oncol
; 7(6): 101008, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36034194
17.
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1.
J Clin Oncol
; 40(12): 1291-1300, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260265
18.
Surgical approach and oncologic outcomes following multidisciplinary management of retrorectal sarcomas.
Ann Surg Oncol
; 18(4): 983-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21153886
19.
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
Oncology
; 80(1-2): 50-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21625179
20.
Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.
J Cutan Pathol
; 38(12): 961-6, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22050093